Near potential seems to be 2c or less unfortunately. Hopefully...

Near potential seems to be 2c or less unfortunately. Hopefully some third party involvements triggers interest because this seems to be turning into same as so many others in that we will do this and prove that and trial this but unless it is of commercial interest to a third party unfortunately it doesnt matter. Seems now we are pushing that we will carry out a trial to show we can do something as well or better than someone else is already able to, and i assume has already started to commercialise. Thats nice but unless their customers or clients are prepared to break existing contracts how do we benefit. I know its not that simple but still feels a little like we are an expensive uber cab looking for clients needing a cab into the cell cytoplasm. Most seem to be working out how to do it themselves rather than getting a cab.
seems main reason we are at current sp is still a hangover from sp rise after genentech extension, and no real news on that or deals, and cut off still end of this year.